xyntha 500 i.u. lyophilized powder vial
زينثا 500 وحدة دولية باودر فيال
blood-coagulation factor viii · 500 i.u
20798EGP
- Active ingredient
- blood-coagulation factor viii
- Strength
- 500 i.u
- Form
- powder
- Manufacturer
- wyeth pharmaceuticals company > pfizer scientific office
- Route
- injection
Uses
Used for prevention and treatment of bleeding episodes in patients with hemophilia A.
Do not use if
Contraindicated in patients with known hypersensitivity to factor VIII products or formulation components.
Side effects
Injection-site reactions, headache, fever, hypersensitivity reactions, and inhibitor development may occur.
Warnings
Monitor for hypersensitivity reactions and development of factor VIII inhibitors.
How it works
Replacement therapy that restores deficient coagulation factor VIII activity and promotes normal clot formation.
Storage
Store refrigerated according to manufacturer instructions.